Related Experiment Video
Updated: May 16, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Activated protein C ameliorates Bacillus anthracis lethal toxin-induced lethal pathogenesis in rats
Jyh-Hwa Kau1, Yung-Luen Shih, Te-Sheng Lien
1Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan, ROC.
Bacillus anthracis lethal toxin (LT) activates coagulation in rat lungs, leading to fibrin deposition and increased mortality. Anticoagulant therapy with activated protein C (aPC) reduced mortality by mitigating these effects.
Area of Science:
- Pathology
- Toxicology
- Hematology
Background:
- Lethal toxin (LT) from Bacillus anthracis causes severe lung edema and shock in rats.
- While heart failure is a known mechanism, rapid LT-induced mortality in rats suggests additional contributing factors.
- The role of coagulopathy in LT-mediated lung dysfunction and mortality remains unclear.
Purpose of the Study:
- To investigate the involvement of coagulopathy in LT-mediated pathogenesis in rats.
- To assess the impact of LT on coagulation and fibrinolysis pathways.
- To evaluate the therapeutic potential of activated protein C (aPC) in LT-induced pathogenesis.
Main Methods:
- Examined mortality rates, lung histology, and plasma coagulant levels in LT-treated rats.
- Investigated the effects of activated protein C (aPC) on LT-mediated pathogenesis.
- Analyzed fibrin deposition, D-dimer, and thrombomodulin levels.
Main Results:
- Fibrin depositions were observed in the lungs of LT-treated rats, indicating activated coagulation.
- Elevated plasma D-dimer and thrombomodulin levels were detected in LT-treated rats.
- Treatment with aPC ameliorated LT-induced pathogenesis, reducing mortality and decreasing D-dimer and thrombomodulin levels.
Conclusions:
- Activation of coagulation in lung tissue contributes significantly to mortality in LT-mediated pathogenesis in rats.
- Anticoagulant therapy with aPC shows promise as a therapeutic strategy for anthrax toxin-induced lung injury.
- These findings highlight the critical role of the coagulation-fibrinolysis system in anthrax pathogenesis.
More Related Videos
05:31Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
Published on: May 16, 2025
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013